These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9394095)

  • 1. Cyclic AMP-mediated signal transduction in heart failure: molecular pathophysiology and therapeutic implications.
    Movsesian MA
    J Investig Med; 1997 Oct; 45(8):432-40. PubMed ID: 9394095
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor?
    Marks AR; Reiken S; Marx SO
    Circulation; 2002 Jan; 105(3):272-5. PubMed ID: 11804976
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
    Hata JA; Koch WJ
    Mol Interv; 2003 Aug; 3(5):264-72. PubMed ID: 14993440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic pathways in human heart failure.
    Sucharov CC
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):119-24. PubMed ID: 17187463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart?
    Bridge JH; Savio-Galimberti E
    Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP.
    Colombo F; Gosselin H; El-Helou V; Calderone A
    J Cell Physiol; 2003 May; 195(2):322-30. PubMed ID: 12652658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations in myocardial adrenoceptor transduction systems in health and disease].
    Tobise K; Onodera S
    Kokyu To Junkan; 1991 Apr; 39(4):311-9. PubMed ID: 1648779
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
    Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
    Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy.
    Movsesian MA
    Cardiovasc Res; 2004 Jun; 62(3):450-9. PubMed ID: 15158137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-site phosphorylation of the 280 kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of beta-adrenergic stimulation.
    Boone AN; Rodrigues B; Brownsey RW
    Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):347-54. PubMed ID: 10393092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure.
    Brodde OE; Michel MC; Zerkowski HR
    Cardiovasc Res; 1995 Oct; 30(4):570-84. PubMed ID: 8575005
    [No Abstract]   [Full Text] [Related]  

  • 15. A-kinase anchoring protein targeting of protein kinase A in the heart.
    Ruehr ML; Russell MA; Bond M
    J Mol Cell Cardiol; 2004 Sep; 37(3):653-65. PubMed ID: 15350838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
    Okuda S; Yano M; Doi M; Oda T; Tokuhisa T; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Matsuzaki M
    Circulation; 2004 Feb; 109(7):911-9. PubMed ID: 14757694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.
    Marx SO; Kurokawa J; Reiken S; Motoike H; D'Armiento J; Marks AR; Kass RS
    Science; 2002 Jan; 295(5554):496-9. PubMed ID: 11799244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes.
    Zhang J; Hupfeld CJ; Taylor SS; Olefsky JM; Tsien RY
    Nature; 2005 Sep; 437(7058):569-73. PubMed ID: 16177793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac beta-adrenergic signaling: from subcellular microdomains to heart failure.
    Saucerman JJ; McCulloch AD
    Ann N Y Acad Sci; 2006 Oct; 1080():348-61. PubMed ID: 17132794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
    Devic E; Xiang Y; Gould D; Kobilka B
    Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.